Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621722 · ClinicalTrials.gov registry record · NA
AroMatherapy for Blood and Marrow Transplant PatIENTs (AMBIENT)
A NA study, sponsored by Hackensack Meridian Health.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03621722 is a NA study that has completed, run by Hackensack Meridian Health. The registered enrollment target is 30 participants.
The verdict
NCT03621722, a NA study, has completed, sponsored by Hackensack Meridian Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The study is comparing the difference between the use of Elequil Aromatabs versus standard of care practice treatments on Blood Marrow Transplantation patients.
Interventions
- OTHER Elequil Aromatabs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-02-27 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03621722
The ClinicalTrials.gov registry entry for NCT03621722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Elequil Aromatabs is the first listed.
NCT03621722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03621722 about?
NCT03621722 is a clinical study titled "AroMatherapy for Blood and Marrow Transplant PatIENTs (AMBIENT)". The study is comparing the difference between the use of Elequil Aromatabs versus standard of care practice treatments on Blood Marrow Transplantation patients.
What is the current status of trial NCT03621722?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-02-27. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03621722?
The interventions under investigation include: Elequil Aromatabs (OTHER).
Who is sponsoring clinical trial NCT03621722?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.